The Pharmacy-level asthma medication ratio and population health

Pediatrics

Volumn 135, Issue 6, 2015, Pages 1009-1017

  Beck, Andrew F ^a   Bradley, Courtney L ^b,c,d   Huang, Bin ^a   Simmons, Jeffrey M ^a   Heaton, Pamela C ^d   Kahn, Robert S ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Kroger Patient Care Center   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CICLESONIDE; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL FUMARATE PLUS MOMETASONE FUROATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVALBUTEROL; LONG ACTING DRUG; MOMETASONE FUROATE; MONTELUKAST; SALBUTAMOL; SHORT ACTING DRUG; TRIAMCINOLONE; ANTIASTHMATIC AGENT;

ARTICLE; ASTHMA; CHILD; CHILD HEALTH; CHILD HOSPITALIZATION; CONTROLLED STUDY; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; FEMALE; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PHARMACY; POVERTY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEASONAL VARIATION; HEALTH STATUS; PRESCHOOL CHILD; PRESCRIPTION; STATISTICS AND NUMERICAL DATA;

ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DRUG PRESCRIPTIONS; FEMALE; HEALTH STATUS; HUMANS; MALE; PHARMACEUTICAL SERVICES; RETROSPECTIVE STUDIES;

EID: 84964697536     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-3796     Document Type: Article

References (37)

1. Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ. Status of childhood asthma in the United States, 1980-2007. Pediatrics. 2009;123(suppl 3):S131-S145
2. Akinbami LJ, Moorman JE, Liu X. Asthma prevalence, health care use, and mortality: United States, 2005-2009. Natl Health Stat Rep. 2011;32:1-14
3. Beck AF, Huang B, Simmons JM, et al. Role of financial and social hardships in asthma racial disparities. Pediatrics. 2014;133(3):431-439
4. Beck AF, Moncrief T, Huang B, et al. Inequalities in neighborhood child asthma admission rates and underlying community characteristics in one US county. J Pediatr. 2013;163(2): 574-580
5. Williams DR, Sternthal M, Wright RJ. Social determinants: taking the social context of asthma seriously. Pediatrics. 2009;123(suppl 3):S174-S184
6. Wright RJ, Subramanian SV. Advancing a multilevel framework for epidemiologic research on asthma disparities. Chest. 2007;132(suppl 5): 757S-769S
7. Lintzenich A, Teufel RJ II, Basco WT Jr. Under-utilization of controller medications and poor follow-up rates among hospitalized asthma patients. Hosp Pediatr. 2011;1(1):8-14
8. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics. 2001; 107(4):706-711
9. Finkelstein JA, Lozano P, Farber HJ, Miroshnik I, Lieu TA. Underuse of controller medications among Medicaidinsured children with asthma. Arch Pediatr Adolesc Med. 2002;156(6): 562-567
10. Wilson SE, Leonard A, Moomaw C, Schneeweiss S, Eckman MH. Underuse of controller medications among children with persistent asthma in the Ohio medicaid population: evolving differences with new medications. Ambul Pediatr. 2005;5(2):83-89
11. Gottlieb DJ, Beiser AS, O'Connor GT. Poverty, race, and medication use are correlates of asthma hospitalization rates. A small area analysis in Boston. Chest. 1995;108(1):28-35
12. Amstislavski P, Matthews A, Sheffield S, Maroko AR, Weedon J. Medication deserts: survey of neighborhood disparities in availability of prescription medications. Int J Health Geogr. 2012;11: 48
13. Bollinger ME, Mudd KE, Boldt A, Hsu VD, Tsoukleris MG, Butz AM. Prescription fill patterns in underserved children with asthma receiving subspecialty care. Ann Allergy Asthma Immunol. 2013;111(3): 185-189
14. Fischer MA, Stedman MR, Lii J, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25(4):284-290
15. Mansour ME, Lanphear BP, DeWitt TG. Barriers to asthma care in urban children: parent perspectives. Pediatrics. 2000;106(3):512-519
16. Pollack CE, Armstrong K. Accountable care organizations and health care disparities. JAMA. 2011;305(16): 1706-1707
17. Hacker K, Walker DK. Achieving population health in accountable care organizations. Am J Public Health. 2013; 103(7):1163-1167
18. Stine NW, Chokshi DA, Gourevitch MN. Improving population health in US cities. JAMA. 2013;309(5):449-450
19. Schatz M, Nakahiro R, Crawford W, Mendoza G, Mosen D, Stibolt TB. Asthma quality-of-care markers using administrative data. Chest. 2005;128(4): 1968-1973
20. Vernacchio L, Trudell EK, Muto JM. Correlation of care process measures with childhood asthma exacerbations. Pediatrics. 2013;131(1):e136-e143
21. Andrews AL, Simpson AN, Basco WT Jr, Teufel RJ II. Asthma medication ratio predicts emergency department visits and hospitalizations in children with asthma. Medicare Medicaid Res Rev. 2013;3(4)
22. Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a communitybased medication therapy management program for asthma. J Am Pharm Assoc (2003). 2006;46(2):133-147
23. van Boven JF, Hiddink EG, Stuurman-Bieze AG, Schuiling-Veninga CC, Postma MJ, Vegter S. The pharmacists' potential to provide targets for interventions to optimize pharmacotherapy in patients with asthma. Int J Clin Pharmacol. 2013; 35(6):1075-1082
24. Schatz M, Zeiger RS. Improving asthma outcomes in large populations. J Allergy Clin Immunol. 2011;128(2):273-277
25. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Available at: http://www.cdc.gov/nchs/icd/icd9cm.htm. Accessed May 25, 2014
26. Bosnjakovic E. INSIGHT Database. Columbus, OH: Ohio Hospital Association; 2009
27. American FactFinder. 2013. Available at: http://factfinder2.census.gov/faces/nav/jsf/pages/searchresults.xhtml?refresh=t. Accessed July 12, 2013
28. Measures HEDIS. 2014. Available at: http://www.ncqa.org. Accessed May 25, 2014
29. Yong PL, Werner RM. Process quality measures and asthma exacerbations in the medicaid population. J Allergy Clin Immunol. 2009;124(5):961-966
30. Schatz M, Zeiger RS, Vollmer WM, et al. The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes. Chest. 2006;130(1):43-50
31. Find Shortage Areas. MUA/P by State and County. 2014. Available at: http://muafind.hrsa.gov. Accessed December 29, 2014
32. Performance Measures PQA. 2014. Available at: http://pqaalliance.org/measures/default.asp. Accessed June 15, 2014
33. Hardt NS, Muhamed S, Das R, Estrella R, Roth J. Neighborhood-level hot spot maps to inform delivery of primary care and allocation of social resources. Perm J. 2013;17(1):4-9
34. Miranda ML, Ferranti J, Strauss B, Neelon B, Califf RM. Geographic health information systems: a platform to support the "triple aim." Health Aff (Millwood). 2013;32(9):1608-1615
35. González-Martin G, Joo I, Sánchez I. Evaluation of the impact of a pharmaceutical care program in children with asthma. Patient Educ Couns. 2003;49(1):13-18
36. Stergachis A, Gardner JS, Anderson MT, Sullivan SD. Improving pediatric asthma outcomes in the community setting: does pharmaceutical care make a difference? J Am Pharm Assoc (Wash). 2002;42(5):743-752
37. Williams DR, Costa MV, Odunlami AO, Mohammed SA. Moving upstream: how interventions that address the social determinants of health can improve health and reduce disparities. J Public Health Manag Pract. 2008;14(suppl):S8-S17